Item Quick Inventory News Today

Check out this broad range of innovative medications in development with the goal of providing psychiatric clinicians with novel treatments in the quest to decrease patient suffering and improve function and quality of life.

Since 2006, STAR*D stands out as an icon guiding treatment decisions of major depressive disorder. But what if it is broken?

In one of the first studies to compare efficacy of IV and intranasal ketamine, results suggest a faster response for the IV form -- although, at the end, overall response was similar.

Psychedelic psilocybin in magic mushrooms outperformed leading depression treatment Psilocybin appeared to treat depression more quickly, for longer and with few side effects than antidepressant escitalopram. Updated Subscribe When you subscribe we will use the information you provide to send you these newsletters. Your information will be used in accordance with ourPrivacy Notice. Thank you for subscribingWe have more newslettersShow meSee ourprivacy notice The psychedelic drug found in magic ...

The psychedelic compound found in magic mushrooms may be at least as effective as a leading antidepressant medication in a therapeutic setting, a new study suggests. Researchers compared the therapeutic potential of psilocybin – found in the mushrooms – with a six-week course of the antidepressant escitalopram in 59 people with moderate to severe depression. They found that, while depression scores were reduced in both groups, the reductions occurred more quickly in the psilocybin group and...